Invicta Diagnostic logo

Invicta Diagnostic financials and balance sheet

NSE: INVICTAHealthcare Services

Last close ₹60.50down ₹4.20 (6.49%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹64.70.

Range of traded prices from listing on 8 Dec 2025 to 23 Oct 2026
₹58.10Low, 5 Mar 2026₹105.00High, 8 Dec 2025
Market cap
₹76 Cr
P/E
15.5
P/B
1.5
Dividend yield
Nonesince listing in Dec 2025
ROE
9.8%
ROCE
12.2%
Debt to equity
0.07
Volume, NSE
8,000100.0% delivered

1 year at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Invicta Diagnostic annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue32
  2. Materials and goods−2.7
  3. Employee costs−4.9
  4. Other expenses−15
  5. Operating profit9.8
  6. Depreciation−3.2
  7. Other income+0.7
  8. One-off items0.0
  9. Finance costs−0.2
  10. Profit before tax7.0
  11. Tax−2.1
  12. Net profit4.9

What the company owns

  • Plant, investments and other assets₹37 Cr
  • Cash and bank₹22 Cr
  • Inventory₹1 Cr
  • Receivables₹1 Cr

What pays for it: net worth and liabilities

  • Net worth₹50 Cr
  • Other liabilities₹5 Cr
  • Borrowings₹4 Cr
  • Owed to suppliers₹2 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Invicta Diagnostic half-yearly results

₹ croreMar 2026Filed 18 May
Revenue from operations32.4
22.6
Materials and goods bought2.7
Employee costs4.9
Other expenses15.0
Operating profit before depreciation9.8
Operating margin30.2%
Materials, % of revenue8.4%
Employee costs, % of revenue15.1%
Other expenses, % of revenue46.3%
Depreciation and amortisation3.2
Operating profit after depreciation6.5
Other income0.7
Finance costs0.2
One-off items0.0
Profit before tax7.0
2.1
4.9
Net margin15.1%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2026Filed 18 May
49.9
Share capital12.6
Reserves37.4
3.7
7.2
3.2
Total assets60.2
25.9
34.3
Net debt−18.5
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2026Filed 18 May
2.9
12.2
2.4
Receivables0.9
Inventories−0.1
Payables1.5
Other working capital0.1
Tax paid−1.0
Capital spending13.0
Free cash flow−10.0
−13.7
30.8
Dividends paid0.0
Shares bought back0.0
Shares issued29.8
Net change in cash20.1
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2026Filed 18 May
Earnings per share₹4.90
Diluted earnings per share₹4.90
Book value per share₹39.71
Shareholder yield−37.7%
Market cap at the year end (₹ crore)79.2

Ratios

Consolidated, years to March.Invicta Diagnostic PE ratio and valuation

RatioMar 2026Filed 18 May
Return on equity9.8%
Return on capital employed12.2%
Cash conversion60.2%
Interest cover33.4
Debt to equity0.07
Receivable days6
Inventory days80
Payable days255
Cash conversion cycle, days−169
Working capital days83
Asset turnover0.54
Assets per rupee of net worth1.21
Sales per rupee of plant1.69
Capital spending to depreciation3.99
Plant being built, % of plant in use0.0%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
8.1%
Cash from operations against operating profit
30.0%

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations2.9
Cash from investing−13.7
Cash from financing30.8
Capital spending13.0
Dividends paid0.0
Shares bought back0.0
Shares issued for cash29.8
Borrowings raised2.4
Borrowings repaid2.3

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2026
Altman Z-scorePublished threshold 1.816.94
Effective tax ratePublished threshold 17.16 per cent30.47
Tax charged less tax paid, % of profitOur threshold 10 percentage points15.86
A threshold marked as ours has no published figure; it is the line we read the check against.